Article thumbnail

Glucose-lowering effect of DLBS3233 is mediated through phosphorylation of tyrosine and upregulation of PPARγ and GLUT4 expression

By Olivia Mayasari Tandrasasmita, Deasy Diah Wulan, Florensia Nailufar, James Sinambela and Raymond Rubianto Tjandrawinata
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. Activation of insulin receptors by lagerstroemin.
  2. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic effect of thiazolidinediones.
  3. An extract of Lagerstroemia speciosa L has insulin like glucose uptake stimulatory and adipocytes differentiation-inhibitory activities in 3T3-L1 cells.
  4. Cellular mechanisms of insulin resistance.
  5. Effect of vanadyl sulfate on fructoseinduced insulin resistance rat.
  6. Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting beta-cells.
  7. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents.
  8. (1999). Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.
  9. Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. PPAR Res.
  10. (2004). Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem.
  11. Limitation of the homeostasis model assessment to predict insulin resistance and beta-cell dysfunction in older people.
  12. (1997). Physiological role of Akt in insulinstimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol.
  13. (1998). PPARγ induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPα during the conversion of 3T3 fibroblasts into adipocytes.
  14. (2005). Role of PPARγ, transcriptional cofactor and adiponectin in the regulation of nutrient metabolism, adipogenesis and insulin action: View from the chair. Int J Obes.
  15. (1999). Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice. J Lipid Res.
  16. Signaling pathways in insulin action: Molecular targets of insulin resistance.
  17. Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells.
  18. (2001). The adipocytesecreted protein Acrp30 enhances hepatic insulin action. Nat Med.
  19. The hormone resistin links obesity to diabetes.
  20. (2002). The mechanism of action of PPARs. Annu Rev Med.
  21. The reaction of pentoses with anthrone.
  22. Therapeutic index for rosiglitazone in dietery obese rats: Separation of efficacy and haemodilution.
  23. (1996). Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes.
  24. (2004). Tyrosine phosphorylation-dependent PI3 kinase/Akt signal transduction regulates TGFβ-induced fibronectin expression in mesangial cells. Cell Signal.